Design of bioactive chitosan-adenosine composite coatings for vascular stents
Bibliographic record
Abstract
No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.
Source: Not provided · Quality: missing
Research context
OpenAlex topics: Nanocomposite Films for Food Packaging · Infectious Aortic and Vascular Conditions · Polymer Surface Interaction Studies
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (78)
Show source-provided references
1. Electrophoretic deposition and characterization of composite chitosan/Eudragit E 100 or poly(4-vinylpyridine)/mesoporous bioactive glass nanoparticles coatings on pre-treated titanium for implant applications10.1016/j.surfcoat.2024.130542 ↗
2. A.c. impedance study on the interfacial properties of passivated Ti13Zr13Nb alloy in physiological saline solution10.1002/sia.5383 ↗
3. Vascular stents - materials and manufacturing technologies
4. Review of recent progress in vascular stents: From conventional to functional vascular stents
5. Current status and future direction of metallic and polymeric materials for advanced vascular stents10.1016/j.pmatsci.2022.100922 ↗
6. 12 - Chemistry of targeted immobilization of biomediators
7. Electrochemically deposition of catechol-chitosan hydrogel coating on coronary stent with robust copper ions immobilization capability and improved interfacial biological activity10.1016/j.ijbiomac.2021.03.158 ↗
8. Mechanically robust biodegradable stents with theragenerative vascular responses via combined 3D printing and janus nanoengineering10.1002/advs.202523965 ↗
9. Research of chitosan coatings deposited by electrophoretic deposition method at various voltage and time parameters10.1016/j.matchemphys.2024.128984 ↗
10. A review of chitosan-based multifunctional nanocomposites for drug/gene/protein delivery and gene therapy in cancer treatments: promises, challenges and outlooks10.1016/j.ijbiomac.2025.141394 ↗
11. A high-performance chitosan-grafted Cu(Ⅱ) coating improves endothelialization and mitigates the degradation of biodegradable magnesium alloy stents10.1016/j.biomaterials.2025.123161 ↗
12. Changes in adenosine deaminase activity and endothelial dysfunction after mild coronavirus disease-201910.3390/ijms241713140 ↗
13. Molecular mechanisms involved in adenosine-induced endothelial cell barrier enhancement10.1016/j.vph.2009.12.008 ↗
14. Therapeutic perspectives of adenosine deaminase inhibition in cardiovascular diseases10.3390/molecules25204652 ↗
15. Role of A1 adenosine receptor in cardiovascular diseases: Bridging molecular mechanisms with therapeutic opportunities10.1016/j.yexmp.2025.104952 ↗
16. Adenosine and the treatment of supraventricular tachycardia10.1016/0002-9343(92)90784-9 ↗
17. Osteogenic and osteoclastic differentiation by control release of adenosine within PEI/HA/Collagen composite coatings
18. The impaired distribution of adenosine deaminase isoenzymes in multiple sclerosis plasma and cerebrospinal fluid10.3389/fnmol.2022.998023 ↗
19. Layer-by-layer deposition of bioactive layers on magnesium alloy stent materials to improve corrosion resistance and biocompatibility
20. Influence of surface modification of titanium and its alloys for medical implants on their corrosion behavior10.3390/ma15217556 ↗
21. Cytocompatibility, antibacterial, and corrosion properties of chitosan/polymethacrylates and chitosan/poly(4-vinylpyridine) smart coatings, electrophoretically deposited on nanosilver-decorated titania nanotubes10.1002/jbm.b.35332 ↗
22. An improved technique for determining hardness and elastic modulus using load and displacement sensing indentation experiments10.1557/JMR.1992.1564 ↗
23. M.E. Niezgodziński, T. Niezgodziński, Strength formulas, charts and tables (in Polish: Wzory wykresy i tablice wytrzymałościowe); Wydawnictwo Naukowo Techniczne, 1996.
24. N. Anwar, F.A. Najam, Chapter Two - Understanding Cross-Sections, in: N. Anwar, F.A. Najam (Eds.), Structural Cross Sections, Butterworth-Heinemann, 2017: pp. 39–136. https://doi.org/10.1016/B978–0-12–804443-8.00002–6.10.1016/B978-0-12-804443-8.00002-6 ↗
25. Chapter 3 - Scaling Laws
26. A simple adhesion assay for studying interactions between platelets and endothelial cells in vitro10.1007/s10616-010-9256-2 ↗
27. Fabrication and characterisation of the cytotoxic and antibacterial properties of chitosan-cerium oxide porous scaffolds10.3390/antibiotics12061004 ↗
28. Spectroscopic studies on the temperature-dependent molecular arrangements in hybrid chitosan/1,3-β-D-glucan polymeric matrices10.1016/j.ijbiomac.2020.05.155 ↗
29. AFM Studies of chitosan, gold-chitosan, and silver-chitosan films morphology10.1002/masy.201900068 ↗
30. Study of nanohydroxyapatite coatings prepared by the electrophoretic deposition method at various voltage and time parameters10.3390/ma17102242 ↗
31. The potential of electropolymerized crosslinked PEGDMA coating on steel for further functionalization: Surface parameters and HMEC-1 cells attachment correlations10.1016/j.apsusc.2023.157761 ↗
32. Improved hemocompatibility on superhemophobic micro–nano-structured titanium surfaces10.3390/bioengineering10010043 ↗
33. Recent developments in blood-compatible superhydrophobic surfaces10.3390/polym14061075 ↗
34. Opposing effects of adenosine and inosine in human subcutaneous fibroblasts may be regulated by third party ADA cell providers10.3390/cells9030651 ↗
35. Pharmacology of adenosine receptors: the state of the art10.1152/physrev.00049.2017 ↗
36. Adenosine enhances nitric oxide production by vascular endothelial cells10.1152/ajpcell.1995.269.2.C519 ↗
37. Adenosine receptors: therapeutic aspects for inflammatory and immune diseases10.1038/nrd2638 ↗
38. Adenosine receptor agonist HE-NECA enhances antithrombotic activities of cangrelor and prasugrel in vivo by decreasing of fibrinogen density in thrombus10.3390/ijms22063074 ↗
39. Influence of ultrasound on the characteristics of CaP coatings generated via the micro-arc oxidation process in relation to biomedical engineering10.1021/acsbiomaterials.3c01433 ↗
40. Antibacterial and bioactivity of silver substituted hydroxyapatite/TiO2 nanotube composite coatings on titanium10.1016/j.apsusc.2014.07.027 ↗
41. Properties of chitosan/CuNPs coatings electrophoretically deposited on TiO2 nanotubular oxide layer of Ti13Zr13Nb alloy10.1016/j.matlet.2021.130982 ↗
42. The effect of pretreated titanium surface topography on the properties of electrophoretically deposited chitosan coatings from ethanol-based suspensions10.1007/s11661-025-07756-x ↗
43. Electrophoretic deposition and characterization of composite chitosan/Eudragit E 100 or poly(4-vinylpyridine)/mesoporous bioactive glass nanoparticles coatings on pre-treated titanium for implant applications10.1016/j.surfcoat.2024.130542 ↗
44. Mechanical properties of stent–graft materials
45. Breaking the limit of Young’s modulus in low-cost Ti–Nb–Zr alloy for biomedical implant applications10.1016/j.jallcom.2020.154401 ↗
46. Temperature characteristics of nitinol spiral stents
47. Biomechanical characterization of the balloon-expandable slotted tube stents
48. Mechanical performance of PLLA stent
49. Mechanical guidelines on the properties of human healthy arteries in the design and fabrication of vascular grafts: experimental tests and quasi-linear viscoelastic model
50. Influence of stent flexibility on artery wall stress and wall shear stress in bifurcation lesions10.2147/MDER.S275883 ↗
51. Electrophoretic deposition and characteristics of chitosan–nanosilver composite coatings on a nanotubular TiO2 layer10.3390/coatings10030245 ↗
52. Mechanical properties and wear susceptibility determined by nanoindentation technique of Ti13Nb13Zr titanium alloy after “direct laser writing10.3390/ma16134834 ↗
53. Chitosan-nanogold and chitosan-nanozinc electrodeposited coatings for biomedical applications10.1002/jbm.b.35571 ↗
54. A mechanistic analysis of delamination of elastic coatings from the surface of plastically deformed stents10.1016/j.ijsolstr.2021.111051 ↗
55. Webbing and delamination of drug eluting stent coatings10.1007/s10439-015-1490-5 ↗
56. Coating irregularities of durable polymer-based drug-eluting stents as assessed by scanning electron microscopy10.4244/EIJV5I1A24 ↗
57. Modeling and experimental studies of coating delamination of biodegradable magnesium alloy cardiovascular stents10.1021/acsbiomaterials.8b00700 ↗
58. In-vitro blood and vascular compatibility of sirolimus-eluting organic/inorganic hybrid stent coatings10.1016/j.colsurfb.2019.04.018 ↗
59. Surface modification strategies to improve titanium hemocompatibility: A comprehensive review10.1039/D1MA00367D ↗
60. Surface modification strategies for improved hemocompatibility of polymeric materials: a comprehensive review10.1039/D3RA08738G ↗
61. Fluorinated hydrophobic silk as platelet compatible coatings for platelet conservation and storage applications10.1002/adfm.202508074 ↗
62. Ta ion implanted nanoridge-platform for enhanced vascular responses10.1016/j.biomaterials.2019.119461 ↗
63. The effect of topography of polymer surfaces on platelet adhesion10.1016/j.biomaterials.2009.11.022 ↗
64. Influence of nanoporesize on platelet adhesion and activation10.1007/s10856-008-3449-7 ↗
65. A biomimetic hydrogel coating with exogenous/endogenous dual-pathway nitric oxide release for synergistic functional regulation of magnesium alloy stents10.1016/j.colsurfa.2026.140086 ↗
66. Adenosine and adenosine receptor-mediated action in coronary microcirculation10.1007/s00395-021-00859-7 ↗
67. B.N. Cronstein, Adenosine: an endogenous regulator of innate immunity10.1016/j.it.2003.11.003 ↗
68. Prolonged activation of cAMP signaling leads to endothelial barrier disruption via transcriptional repression of RRAS10.1096/fj.201700818RRR ↗
69. Adenosine stimulates proliferation of human endothelial cells in culture10.1152/ajpheart.1993.265.1.H131 ↗
70. Differential expression of adenosine receptors in human endothelial cells10.1161/01.RES.0000012203.21416.14 ↗
71. Hypoxic activation of adventitial fibroblasts*: role in vascular remodeling10.1378/chest.122.6_suppl.326S ↗
72. Exomeres from adventitial fibroblasts of spontaneously hypertensive rats promote vascular remodelling via transferring osteopontin10.1002/jev2.70146 ↗
73. Inhibition of LPS-stimulated ecto-adenosine deaminase attenuates endothelial cell activation10.1016/j.yjmcc.2019.01.004 ↗
74. Adenosine A2A and A2B receptors in cultured human and porcine coronary artery endothelial cells10.1152/ajpheart.2000.279.2.H650 ↗
75. A2A and A2B adenosine receptors: The extracellular loop 2 determines high (A2A) or low affinity (A2B) for adenosine10.1016/j.bcp.2019.113718 ↗
76. International union of pharmacology. XXV. Nomenclature and classification of adenosine receptors10.1016/S0031-6997(24)01511-4 ↗
77. Cardiac mitochondria dysfunction in dyslipidemic mice10.3390/ijms231911488 ↗
78. Increased activity of vascular adenosine deaminase in atherosclerosis and therapeutic potential of its inhibition10.1093/cvr/cvw203 ↗